Helios Biotechnology JSC (HOSE:HSL)

Helios Biotechnology JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2017	Jan 1, 2017
Cash & Equivalents	21,413	70,602	80,146	63,844	27,915	21,649
Trading Asset Securities	33,096	85,105	60,684	-	-	-
Cash & Short-Term Investments	54,510	155,707	140,830	63,844	27,915	21,649
Cash Growth	-46.04%	10.56%	120.59%	128.71%	28.94%	-
Accounts Receivable	5,606	-	23,901	107,941	45,566	29,700
Other Receivables	89,043	132,636	2,410	2,116	113.35	-
Receivables	94,648	132,636	98,801	163,107	45,679	29,700
Inventory	129.21	-	3,499	15,494	35,960	36,418
Prepaid Expenses	-	79.9	36.72	100.31	-	15.94
Other Current Assets	35,616	1,940	10,233	23,617	14,475	8,973
Total Current Assets	184,903	290,363	253,400	266,163	124,029	96,755
Property, Plant & Equipment	13,080	35,023	41,984	46,207	27,808	29,574
Long-Term Investments	183,889	68,319	73,989	67,529	14,000	14,000
Goodwill	311.01	336.37	-	-	-	-
Other Long-Term Assets	48,547	159,957	99,967	100,216	4,115	4,028
Total Assets	481,204	553,998	469,339	480,115	169,951	144,358

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2017	Jan 1, 2017
Accounts Payable	1,842	123.76	2,842	18,480	610.22	44.55
Accrued Expenses	9,087	9,098	8,912	8,903	-	28
Short-Term Debt	-	3,586	1,524	-	-	-
Current Portion of Long-Term Debt	5,582	-	1,702	1,165	-	-
Current Portion of Leases	-	-	2,945	2,188	-	-
Current Income Taxes Payable	2,713	3,139	429.54	870.75	-	-
Other Current Liabilities	9,500	83,524	243.61	160.4	1,402	25.93
Total Current Liabilities	28,724	99,470	18,598	31,768	2,013	98.48
Long-Term Debt	-	-	4,048	5,230	-	-
Long-Term Leases	-	-	-	2,945	-	-
Long-Term Deferred Tax Liabilities	2,425	2,488	71.04	67.21	-	-
Total Liabilities	31,150	101,958	22,717	40,009	2,013	98.48

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2017	Jan 1, 2017
Common Stock	385,674	385,674	385,674	353,835	126,000	126,000
Retained Earnings	14,179	16,153	16,170	41,658	41,939	18,259
Comprehensive Income & Other	39,750	39,750	39,750	39,750	-	-
Total Common Equity	439,603	441,577	441,593	435,243	167,939	144,259
Minority Interest	10,451	10,464	5,028	4,863	-	-
Shareholders' Equity	450,054	452,040	446,622	440,106	167,939	144,259
Total Liabilities & Equity	481,204	553,998	469,339	480,115	169,951	144,358

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2017	Jan 1, 2017
Total Debt	5,582	3,586	10,219	11,528	-	-
Net Cash (Debt)	48,927	152,121	130,611	52,316	27,915	21,649
Net Cash Growth	-51.56%	16.47%	149.66%	87.41%	28.94%	-
Net Cash Per Share	1145.21	3944.28	3386.58	1313.41	1356.17	2319.03
Filing Date Shares Outstanding	15.84	38.57	38.57	39.83	20.58	20.58
Total Common Shares Outstanding	15.84	38.57	38.57	39.83	20.58	20.58
Working Capital	156,179	190,893	234,802	234,396	122,016	96,657
Book Value Per Share	27749.17	11449.49	11449.92	10926.81	8158.77	7008.39
Tangible Book Value	388,819	441,240	441,593	435,243	167,939	144,259
Tangible Book Value Per Share	24543.49	11440.77	11449.92	10926.81	8158.77	7008.39
Buildings	-	33,063	9,994	9,994	9,994	9,994
Machinery	-	18,257	47,664	46,517	21,415	21,415
Construction In Progress	-	-	-	-	1,010	-

Data Source: S&P Global Market Intelligence Last updated: Nov 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error